These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. Kim J, Lim YM, Rheem I, Lee Y, Lee JC, Seol SY, Lee YC, Cho DT. FEMS Microbiol Lett; 2005 Apr 01; 245(1):93-8. PubMed ID: 15796985 [Abstract] [Full Text] [Related]
23. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance. Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M. Int J Infect Dis; 2008 May 01; 12(3):256-64. PubMed ID: 17981482 [Abstract] [Full Text] [Related]
24. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases. Mushtaq S, Ge Y, Livermore DM. Antimicrob Agents Chemother; 2004 Apr 01; 48(4):1313-9. PubMed ID: 15047535 [Abstract] [Full Text] [Related]
26. AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. Black JA, Moland ES, Thomson KS. J Clin Microbiol; 2005 Jul 01; 43(7):3110-3. PubMed ID: 16000421 [Abstract] [Full Text] [Related]
27. Identification and characterization of ceftriaxone resistance and extended-spectrum beta-lactamases in Malawian bacteraemic Enterobacteriaceae. Gray KJ, Wilson LK, Phiri A, Corkill JE, French N, Hart CA. J Antimicrob Chemother; 2006 Apr 01; 57(4):661-5. PubMed ID: 16537341 [Abstract] [Full Text] [Related]
29. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase. Kang CI, Pai H, Kim SH, Kim HB, Kim EC, Oh MD, Choe KW. J Antimicrob Chemother; 2004 Dec 01; 54(6):1130-3. PubMed ID: 15486080 [Abstract] [Full Text] [Related]
30. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases. Rodríguez-Baño J, Miró E, Villar M, Coelho A, Gozalo M, Borrell N, Bou G, Conejo MC, Pomar V, Aracil B, Larrosa N, Agüero J, Oliver A, Fernández A, Oteo J, Pascual A, Navarro F. J Infect; 2012 Feb 01; 64(2):176-83. PubMed ID: 22138600 [Abstract] [Full Text] [Related]
38. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Lewis JS, Herrera M, Wickes B, Patterson JE, Jorgensen JH. Antimicrob Agents Chemother; 2007 Nov 15; 51(11):4015-21. PubMed ID: 17724160 [Abstract] [Full Text] [Related]
39. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). Goossens H, Grabein B. Diagn Microbiol Infect Dis; 2005 Dec 15; 53(4):257-64. PubMed ID: 16360549 [Abstract] [Full Text] [Related]
40. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Bush K. Curr Opin Microbiol; 2010 Oct 15; 13(5):558-64. PubMed ID: 20920882 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]